A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
Not yet recruiting
- Conditions
- Glioblastoma Multiforme
- Registration Number
- NCT05958485
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation.
Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Diagnosis of glioblastoma multiforme
- No prior treatment for glioblastoma multiforme
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria
- Female patients who are currently pregnant or nursing
- Enrolled in another research study
- Patients who are currently receiving any other investigational drug.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a glioblastoma multiforme clinical study. 3 months Number of glioblastoma multiforme study participants who remain in clinical trial until completion. 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States